Question 1

What are the most cited papers from Codex Biosolutions (United States)?

Accepted Answer

The most cited paper from Codex Biosolutions (United States) is "Structural impact on SARS-CoV-2 spike protein by D614G substitution" (Jun Zhang, Yongfei Cai, Tianshu Xiao et al., 2021), with 477 citations. Next come "Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant" (310) and "Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants" (253).

Question 2

Which research topics does Codex Biosolutions (United States) publish most on?

Accepted Answer

By volume in 2022-now: SARS-CoV-2 and COVID-19 Research, Tissue Engineering and Regenerative Medicine, CAR-T cell therapy research and Monoclonal and Polyclonal Antibodies Research.

Question 3

Which fields of science does Codex Biosolutions (United States) work in?

Accepted Answer

In all years, 48% of research at Codex Biosolutions (United States) is in Health Sciences, 38% in Life Sciences. Its largest fields are Medicine (48%), Biochemistry, Genetics and Molecular Biology (21%), Immunology and Microbiology (8%). It does 1.5× the world's share of Life Sciences.

Question 4

Is Codex Biosolutions (United States)'s research output growing?

Accepted Answer

Output in 2022-2025 was 48% lower than in 2018-2021.